ProQR Therapeutics N.V. logo
ProQR Therapeutics N.V. PRQR
$ 3.62 0.28%

Annual report 2023
added 11-09-2024

report update icon

ProQR Therapeutics N.V. Financial Statements 2011-2024 | PRQR

Annual Financial Statements ProQR Therapeutics N.V.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- - 68.7 M 188 M 291 M 454 M 85 M 96.9 M 123 M 223 M - - -

Shares

- - 64.2 M 41 M 41 M 34.1 M 25.4 M 23.3 M 23.3 M 11.1 M - - -

Historical Prices

2.38 1.55 1.07 4.57 7.09 13.3 3.35 4.05 4.34 18.8 - - -

Net Income

- - -61.7 M -46.6 M -56.5 M -36.9 M -43.6 M -39.1 M -20.8 M -12.1 M -3.25 M - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - 313 K - - -

Operating Income

- - -57.2 M -42.4 M -57.4 M -36.3 M -40.5 M -39.6 M -27 M - - - -

Interest Expense

1.2 M - 3.4 M 2.04 M - - - - - - - - -

EBITDA

- - -57.2 M -42.4 M -57.4 M -36.3 M -40.5 M -38.5 M -26.6 M -16.3 M -3.19 M - -

Operating Expenses

41.4 M 69.5 M 59.6 M 51.8 M 59.4 M 42.1 M 42 M 39.8 M 27 M 16.5 M - - -

General and Administrative Expenses

- - 17.4 M 13.7 M 12.9 M 12.5 M 10.8 M 9.48 M 6.84 M 6.51 M 786 K - -

All numbers in EUR currency

Quarterly Income Statement ProQR Therapeutics N.V.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - 71.4 M 71.2 M 68.3 M 66.1 M 50.8 M 50.2 M 50.1 M 50 M 49.9 M 47.4 M 38.9 M 38.9 M 38.9 M - 33.4 M 31.9 M - - - 24 M - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - -14.4 M -18.2 M -15.1 M -15.8 M -12.6 M -13.2 M -13.2 M -4.12 M -16.1 M -18.6 M -12.2 M -11.7 M -14.2 M - -5.99 M -7.4 M - - - -11.4 M - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - 1.23 M 239 K 872 K 243 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - -16.9 M -17.3 M -14.6 M -13.2 M -12.1 M -11.7 M -10.9 M -3.36 M -16.5 M -17.4 M -13.4 M -11.8 M -14.7 M - -5.92 M -7.67 M - - - -10.2 M - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - -16.9 M -17.3 M -14.6 M -13.2 M -12.1 M -11.7 M -10.9 M -3.36 M -16.5 M -17.4 M -13.4 M -11.8 M -14.7 M - -5.92 M -7.67 M - - - -10.2 M - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - 18.3 M 17.8 M 15.7 M 13.9 M 12.2 M 11.9 M 11.1 M 12 M 16.7 M 17.8 M 14 M 12.4 M 15.2 M - 8.88 M 8.64 M - - - 10.4 M - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - 4.91 M 5.32 M 4.59 M 4.12 M 3.34 M 3.51 M 2.81 M 3.45 M 3.92 M 3.92 M 2.9 M 2.88 M 3.19 M - 2.58 M 2.65 M - - - 2.89 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in EUR currency